ATMP Manufacturing: Complex Challenges Require Complex Solutions

Commercializing cell and gene therapies is a major problem for manufacturers, even if their products have proven successful in clinical studies. For companies whose therapies do make it to the market, recouping investments can be challenging, given that payers and health care systems often question the high prices associated with advanced therapy medicinal products (ATMPs).